» Articles » PMID: 33828447

Additive Effects of Environmental Enrichment and Ketamine on Neuropathic Pain Relief by Reducing Glutamatergic Activation in Spinal Cord Injury in Rats

Overview
Journal Front Neurosci
Date 2021 Apr 8
PMID 33828447
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Spinal cord injury (SCI) impairs mobility and often results in complications like intractable neuropathic pain. A multi-approach management of this chronic pain condition has been encouraged, but little has been explored of the field. Here, we focus on the effect and underlying mechanism of environmental enrichment (EE), which promotes voluntary social and physical activities, combined with a clinical analgesic, ketamine, on SCI-induced neuropathic pain as well as motor dysfunction. We performed T13 spinal hemisection in rats, which induced unilateral motor impairment and neuropathic pain-like behaviors in the hindlimb. Treatment regimen started a week after SCI, which consists of ketamine administration (30 mg kg day; intramuscular) for 10 days, or EE housing for 20 days, or their combination. Paw withdrawal response to mechanical and thermal stimuli, motor function, burrowing behaviors, and body weight was monitored. Spinal segments at T13 lesion and L4-L6 were collected for histopathological and protein analyses. The joint treatment of EE and ketamine provided greater relief of pain-like behaviors and locomotor recovery than did either paradigm alone. These improvements were associated with reduced cavitation area, astrogliosis, and perilesional phosphorylation of glutamate -methyl-D-aspartate receptor (NMDAR). Concurrently, lumbar spinal analysis of NMDAR-linked excitatory markers in hypersensitization showed reduced activation of NMDAR, mitogen-activated protein kinase (MAPK) family, nuclear factor (NF)-κB, interleukin (IL)-1β signaling, and restored excitatory amino acid transporter 2 level. Our data support a better therapeutic efficacy of the combination, EE, and ketamine, in the attenuation of neuropathic pain and motor recovery by reducing spinal glutamatergic activation, signifying a potential multifaceted neurorehabilitation strategy to improve SCI patient outcome.

Citing Articles

Exploring the Therapeutic Potential of N-Methyl-D-Aspartate Receptor Antagonists in Neuropathic Pain Management.

Puscasu C, Chirita C, Negres S, Blebea N Int J Mol Sci. 2024; 25(20).

PMID: 39456894 PMC: 11507561. DOI: 10.3390/ijms252011111.


Antinociceptive Behavior, Glutamine/Glutamate, and Neopterin in Early-Stage Streptozotocin-Induced Diabetic Neuropathy in Liraglutide-Treated Mice under a Standard or Enriched Environment.

Gateva P, Hristov M, Ivanova N, Vasileva D, Ivanova A, Sabit Z Int J Mol Sci. 2024; 25(19).

PMID: 39409118 PMC: 11477071. DOI: 10.3390/ijms251910786.


The Transcription Factor Tbx5-Dependent Epigenetic Modification Contributes to Neuropathic Allodynia by Activating TRPV1 Expression in the Dorsal Horn.

Lai C, Hsieh M, Chou D, Lin K, Wang H, Yang P J Neurosci. 2024; 44(39).

PMID: 39174351 PMC: 11426380. DOI: 10.1523/JNEUROSCI.0497-24.2024.


Environmental enrichment alleviates hyperalgesia by modulating central sensitization in a nitroglycerin-induced chronic migraine model of mice.

Wang L, Liu X, Zhu C, Wu S, Li Z, Jing L J Headache Pain. 2024; 25(1):74.

PMID: 38724948 PMC: 11083806. DOI: 10.1186/s10194-024-01779-2.


Digital Therapeutics for Improving Effectiveness of Pharmaceutical Drugs and Biological Products: Preclinical and Clinical Studies Supporting Development of Drug + Digital Combination Therapies for Chronic Diseases.

Biskupiak Z, Ha V, Rohaj A, Bulaj G J Clin Med. 2024; 13(2).

PMID: 38256537 PMC: 10816409. DOI: 10.3390/jcm13020403.


References
1.
Paoletti P, Bellone C, Zhou Q . NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci. 2013; 14(6):383-400. DOI: 10.1038/nrn3504. View

2.
Rutten K, Schiene K, Robens A, Leipelt A, Pasqualon T, Read S . Burrowing as a non-reflex behavioural readout for analgesic action in a rat model of sub-chronic knee joint inflammation. Eur J Pain. 2013; 18(2):204-12. DOI: 10.1002/j.1532-2149.2013.00358.x. View

3.
Kaindl A, Degos V, Peineau S, Gouadon E, Chhor V, Loron G . Activation of microglial N-methyl-D-aspartate receptors triggers inflammation and neuronal cell death in the developing and mature brain. Ann Neurol. 2012; 72(4):536-49. DOI: 10.1002/ana.23626. View

4.
Tai L, Yeung S, Cheung C . Enriched Environment and Effects on Neuropathic Pain: Experimental Findings and Mechanisms. Pain Pract. 2018; 18(8):1068-1082. DOI: 10.1111/papr.12706. View

5.
Ramer L, Ramer M, Bradbury E . Restoring function after spinal cord injury: towards clinical translation of experimental strategies. Lancet Neurol. 2014; 13(12):1241-56. DOI: 10.1016/S1474-4422(14)70144-9. View